1. Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages. Issue 6 (1st December 2022) Authors: Hönzke, Katja; Obermayer, Benedikt; Mache, Christin; Fathykova, Diana; Kessler, Mirjana; Dökel, Simon; Wyler, Emanuel; Baumgardt, Morris; Löwa, Anna; Hoffmann, Karen; Graff, Patrick; Schulze, Jessica; Mieth, Maren; Hellwig, Katharina; Demir, Zeynep; Biere, Barbara; Brunotte, Linda; Mecate-Zambran... Journal: European respiratory journal Issue: Volume 60:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗